A61K 51/0402
Carboxylic acid carriers, fatty acids
Official title: {carboxylic acid carriers, fatty acids (amino acids A61K51/0406)}
A61K51/0402 (Carboxylic acid carriers, fatty acids) appears on 263 US grants and 570 published applications in this corpus.
Search patents in A61K- Granted patents
- 263
- Published applications
- 570
- Assignees
- 266
- Inventors
- 1,107
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 3 |
| 2004 | 1 | 10 |
| 2005 | 3 | 3 |
| 2006 | 3 | 4 |
| 2007 | 1 | 9 |
| 2008 | 3 | 13 |
| 2009 | 3 | 13 |
| 2010 | 3 | 12 |
| 2011 | 3 | 10 |
| 2012 | 8 | 14 |
| 2013 | 4 | 15 |
| 2014 | 16 | 17 |
| 2015 | 7 | 20 |
| 2016 | 9 | 26 |
| 2017 | 14 | 18 |
| 2018 | 15 | 23 |
| 2019 | 17 | 25 |
| 2020 | 23 | 38 |
| 2021 | 20 | 40 |
| 2022 | 18 | 41 |
| 2023 | 8 | 48 |
| 2024 | 20 | 48 |
| 2025 | 27 | 76 |
| 2026 | 9 | 42 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies23 Jun 2026US 12,661,417 B2Cornell University
- Compositions and methods for the treatment and imaging of cancer26 May 2026US 12,636,386 B2Board of Regents of the University of Nebraska
- PSMA binder and use thereof28 Apr 2026US 12,612,343 B2Shiya Pharmaceutical, Inc
- Theranostic agents for PSMA positive cancers24 Mar 2026US 12,582,728 B2Memorial Sloan Kettering Cancer Center
- PSMA imaging agents24 Mar 2026US 12,583,887 B2Siemens Medical Solutions USA, Inc.
- 18f-fluorinated fatty acids and uses thereof8 Oct 2026US 2026/0308102 A1Ratio Therapeutics, Inc.
- Complex comprising a psma-targeting compound linked to a lead or thorium radionuclide24 Sep 2026US 2026/0285887 A1Sciencons AS
- Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies17 Sep 2026US 2026/0273111 A1Cornell University
- Use of positron myocardial fatty acid metabolism imaging agent and positron 18f-fdg myocardial glucose imaging agent in pet combined imaging10 Sep 2026US 2026/0263644 A1Beijing Sinotau International Pharmaceutical Technology Co., Ltd.
- Compositions and methods for preventing retention of psma-targeted therapy3 Sep 2026US 2026/0256953 A1
Most cited
By later US patents
- Vitamin-targeted imaging agents155US 7,128,893 B2Endocyte, Inc. · 2006
- Imaging protocols117US 8,644,910 B2Biosensors International Group, Ltd. · 2014
- Methods of treating Parkinson's disease using recombinant adeno-associated vector (rAAV)108US 6,309,634 B1Avigen, Inc. · 2001
- Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof93US 8,668,926 B12014
- Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits87US 6,417,178 B1University of Pittsburgh · 2002